arginine and Glioma

arginine has been researched along with Glioma in 99 studies

Research

Studies (99)

Timeframe	Studies, this research(%)	All Research%
pre-1990	35 (35.35)	18.7374
1990's	18 (18.18)	18.2507
2000's	17 (17.17)	29.6817
2010's	26 (26.26)	24.3611
2020's	3 (3.03)	2.80

Authors

Authors	Studies
Bishop, E; Dandapani, M; Dimitrova, M; Estevez-Cebrero, M; Froggatt, A; Grundy, RG; Mussai, F; Paine, S; Storer, LCD	1
Abrahantes-Pérez, MDC; Barajas-Olmos, F; García-Ortiz, H; Hernández-Cuenca, YE; Jiménez-Morales, JM; Orozco, L; Quiñones-Hinojosa, A; Reyes-Abrahantes, A; Reyes-González, J; Ruiz-García, H	1
Ikegami, T; Ito, A; Kikuchi, M; Konuma, T; Noritsugu, K; Sekine, S; Takase, S; Umehara, T	1
Alves, WA; Hamley, IW; Han, SW; Listik, E; Reza, M; Ruokolainen, J; Silva, ER; Soares, BM	1
Chen, A; Huang, X; Jiang, B; Li, Q; Lin, F; Liu, M; Ma, H; Ouyang, C; Shi, M; Suleman, M; Wang, H; Wang, J; Wen, S; Zhang, J; Zhang, Y; Zhao, W; Zhou, H; Zhou, L	1
Debets, R; French, PJ; Sillevis Smitt, PAE; van Brakel, M; Weenink, B; Wijers, R	1
Kaneko, MK; Kato, Y; Natsume, A	1
Kato Kaneko, M; Kato, Y; Ogasawara, S	1
Ding, Q; Fathallah-Shaykh, HM; Friedman, GK; Gillespie, GY; Han, X; King, PH; Li, R; Nabors, LB; Province, P; Wheeler, CG; Yang, X; You, Z; Zhang, W; Zhao, X	1
Kato, Y	1
Hayashi, Y; Iguchi, Y; Kitamatsu, M; Matsui, H; Michiue, H; Nishiki, T; Takenaka, F	1
ElAyeb, M; Nilges, M; Othman, H; Srairi-Abid, N; Wieninger, SA	1
Black, KL; Espinoza, AJ; Hu, J; Irvin, DK; Ko, MK; Konda, BM; Ong, JM; Sacapano, MR; Shu, Y; Wang, X; Yin, D	1
Almeida, JR; Burbano, RR; Casartelli, C; Clara, CA; Pinto, GR; Rey, JA; Santos, MJ; Yoshioka, FK	1
Heth, J; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Tang, L; Xi, G	1
Bigner, DD; Jin, G; Kato, Y; Kuan, CT; McLendon, RE; Yan, H	1
Bennett, BD; Bittinger, MA; Cantley, LC; Dang, L; Driggers, EM; Fantin, VR; Gross, S; Jang, HG; Jin, S; Keenan, MC; Liau, LM; Marks, KM; Prins, RM; Rabinowitz, JD; Su, SM; Thompson, CB; Vander Heiden, MG; Ward, PS; White, DW; Yen, KE	1
Bremer, J; Capper, D; Harter, PN; Hartmann, C; Jeibmann, A; Reuss, D; Sahm, F; Schittenhelm, J; von Deimling, A	1
Chiriboga, L; Golfinos, JG; Karajannis, MA; von Deimling, A; Williams, SC; Zagzag, D	1
Boult, JK; Jamin, Y; Leiper, JM; Robinson, SP; Walker-Samuel, S; Whitley, GS	1
Almeida, JR; Almeida, LO; Casartelli, C; Clara, CA; Custódio, AC; Pinto, GR; Rey, JA; Santos, MJ	1
Hainfellner, JA; Höftberger, R; Preusser, M; Stary, S; Streubel, B; Wöhrer, A	1
An, N; Fu, Y; Hu, C; Huang, R; Liang, A; Zheng, S; Zheng, Y	1
Chemaitilly, W; Hua, C; Lukose, RC; Merchant, TE; Wu, S	1
Peng, XZ; Tan, XC; Wang, S; Yang, B; Yin, B	1
Knovich, MA; Lesser, GJ; Strowd, RE	1
An, S; Bai, CZ; Choi, S; Nam, K; Park, JS	1
Bianco, ID; Correa, SG; Porporatto, C; Riera, CM	1
Hoff, JT; Hua, Y; Keep, RF; Schallert, T; Xi, G	1
Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, L; Xi, G	1
Fewel, ME; Hoff, JT; Hua, Y; Keep, RF; Muraszko, KM; Schallert, T; Tang, LL; Xi, GH	1
Baralle, D; Bonthron, DT; Charlton, R; Cole, TR; De Vos, M; Glaser, AW; Hayward, BE; Maher, ER; Mann, JR; McKeown, CM; Picton, S; Rankin, J; Sheridan, E; Taylor, GR; Yates, JR	1
Ivanov, V; Kalinovsky, T; Niedzwiecki, A; Rath, M; Roomi, MW	1
Amorim, J; Costa, S; Lima-Ramos, V; Lopes, JM; Pacheco-Figueiredo, L; Pardal, F; Reis, RM; Silva, A	1
Larsson, E; Pontén, J; Westermark, B	1
Bastida, E; Escolar, G; Jamieson, GA; Ordinas, A	1
Schmidlin, A; Wiesinger, H	1
Alak, AM; Cromeens, DM; Flaherty, MJ; Griffith, OW; Gross, SS; Kilbourn, RG; Owen-Schaub, LB; Santee, SM	1
Fresno, M; Muñoz-Fernández, MA	1
Kagaya, A; Kugaya, A; Muraoka, M; Nagaoka, I; Takebayashi, M; Uchitomi, Y; Yamawaki, S; Yokota, N	1
Hayashi, T; Kagaya, A; Kugaya, A; Motohashi, N; Okamoto, Y; Shinno, H; Takebayashi, M; Uchitomi, Y; Yamaji, T; Yamawaki, S	1
Black, KL; Matsukado, K; Nakano, S	1
Bröer, A; Bröer, S; Hamprecht, B	1
Kataoka, Y; Kawachi, R; Kumakura, K; Oishi, R; Shuto, H; Trevin, S	1
Fujiwara, S; Fukui, M; Iwaki, T; Kanaide, H; Moriguchi, M; Natori, Y; Takeshita, I	1
Brecher, AS; König, M; Pugatch, RD; Sobel, RE; Suszkiw, JB; Wasilauskas, VP	1
Fishman, MA; Peake, GT	1
Atta, J; Franz, K; Lemercier, S; Rieger, J; Steinbach, JP; Sulzbacher, A; Thiepold, AL	1
Glas, M; Herrlinger, U; Kebir, S; Mack, F; Niessen, M; Schäfer, N; Schaub, C; Scheffler, B; Stuplich, M	1
Chen, FR; Chen, YS; Chen, ZP; Guo, CC; Mu, YG; Sai, K; Sun, YC; To, TS; Wang, J; Yang, QY; Zhang, ZP	1
Jiang, X; Qin, K; Qin, L; Wang, J; Zeng, Y; Zou, Y	1
Chen, ZP; Jiang, XB; Mu, YG; Sai, K; Shen, D; Yang, QY; Zhang, XH	1
Gu, K; Wang, J; Zhai, X; Zhang, J	1
Cui, Y; Dong, Y; Hu, G; Lu, Y; Luo, C; Wang, J; Wang, Q	1
Bamberg, M; Koch, R; Krauseneck, P; Müller, B; Weller, M	1
Bratengeier, K; Flentje, M; Kölbl, O; Ruprecht, K; Vince, GH; Vordermark, D	1
Feun, LG; Heros, D; Herrera, C; Landy, H; Marini, A; Markoe, A; Robles, C; Savaraj, N	1
Kessinger, A	1
Di Stefano, E; Gerosa, MA; Olivi, A	1
Barrere, M; Bes, A; Fanjaud, G; Geraud, G; Larrue, V	1
Baumann, N; Jacque, C; Kujas, M; Poisson, M; Raoul, M	1
Addison, D; Benoit, B; Dennery, J; Grahovac, Z; Hugenholtz, H; Maroun, JA; Peterson, E; Richard, MT; Russell, N; Stewart, DJ	1
Iwasa, H; Kohno, T; Matsutani, M; Satoh, F; Takakura, K; Yamamoto, H	1
Akanuma, A; Kohno, T; Maehara, T; Nakamura, O; Sano, K; Sato, F; Shitara, N; Takakura, K; Yamamoto, H	1
Canetta, R; D'Incalci, M; Franchin, G; Galligioni, E; Grigoletto, E; Rossi, C; Tirelli, U; Trovò, MG; Tumolo, S; Veronesi, A	1
Schulz, JJ; Speckhart, VJ; Spremulli, E; Wampler, GL	1
Belanger, G; Benoit, B; DaSilva, V; Grahovac, Z; Hugenholtz, H; Richard, MT; Russell, N; Stewart, DJ	1
Dichgans, J; Roth, W; Schmidt, C; Weller, M	1
Dichgans, J; Roth, W; Weller, M; Winter, S	1
Dichgans, J; Groscurth, P; Gulbins, E; Malipiero, U; Trepel, M; Weller, M	1
Bartussek, C; Naumann, U; Weller, M	1
Glaser, T; Weller, M	1
Naumann, U; Weit, S; Weller, M; Wischhusen, J	1
Chen, B; Hu, S; Huang, C	1
Basugi, N; Nomura, K; Sano, K; Shitara, N; Takakura, K; Yamamoto, H	1
Hassoun, J; Paillas, JE; Pellet, W; Peragut, JC; Prince, MA	1
Sano, K; Shitara, N; Takakura, K; Yamamoto, H	1
Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Palangie, T; Parrot, R; Poisson, M; Pouillart, P	1
Buge, A; Poisson, M; Pouillart, P	1
Foley, JF; Kessinger, A; Lemon, HM	1
Bataini, JP; Hauw, JJ; Mashaly, R; Metzger, J; Pertuiset, BF; Poisson, M; Pouillart, P	1
de Tribolet, N; Wagenknecht, L; Zander, E	1
Elie, A; Loubrieu, G; Ribadeau Dumas, JL	1
Aimard, G; Chassard, JL; Devic, M; Tommasi, M; Trouillas, P	1
Buge, A; Gautier, H; Huguenin, P; Morin, P; Palangie, T; Poisson, M; Pouillart, P	1
D'Estienne d'Orves, JF; Paillas, JE; Pellet, W; Pollet, JF	1
Buge, A; Gautier, H; Huguenin, P; Lheritier, J; Mathé, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, HT	1
Levin, VA; Wilson, CB	1
Brouty-Boye, G	1
Gauthier, H; Huguenin, P; Lheritier, J; Mathe, G; Morin, P; Parrot, R; Poisson, M; Pouillart, P; Thy, TH	1
Djuric, LJ; Jeremic, B; Jevremovic, S; Jovanovic, D; Mijatovic, LJ	1
Hildebrand, JG	1
Heuser, K	1
Benoit, B; Grahovac, Z; Hugenholtz, H; Richard, M; Russell, N; Stewart, DJ	1
Burger, PC; Green, SB; Mahaley, MS; Mealey, J; Ransohoff, J; Robertson, JT; Selker, RG; Shapiro, WR; Strike, TA; VanGilder, JC	1
Ali-Osman, F; Dougherty, D; Giblin, J; Rosenblum, ML	1
Bertsch, L; Bouldin, TW; Cush, S; Krigman, MR; Mahaley, MS; Whaley, RA	1
Benoit, B; DaSilva, V; Hugenholtz, H; Maroun, J; Richard, M; Russell, N; Stewart, DJ; Verma, S	1

Reviews

4 review(s) available for arginine and Glioma

Article	Year
MicroRNA delivery systems in glioma therapy and perspectives: A systematic review. Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 349 Topics: Arginine; Brain Neoplasms; Glioma; Humans; Liposomes; MicroRNAs; Nanoparticles; Peptides; Temozolomide	2022
Specific monoclonal antibodies against IDH1/2 mutations as diagnostic tools for gliomas. Brain tumor pathology, 2015, Volume: 32, Issue:1 Topics: Antibodies, Monoclonal; Arginine; Biomarkers, Tumor; Brain Neoplasms; Catalysis; Cytosol; Glioma; Glutarates; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Isocitrates; Ketoglutaric Acids; Mitochondria; Mutation; Oxidation-Reduction	2015
High dose chemotherapy with autologous bone marrow rescue for high grade gliomas of the brain: a potential for improvement in therapeutic results. Neurosurgery, 1984, Volume: 15, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Brain Neoplasms; Carmustine; Combined Modality Therapy; Etoposide; Glioblastoma; Glioma; Humans; Lomustine; Teniposide	1984
Chemotherapy: the agents in current use. Seminars in oncology, 1975, Volume: 2, Issue:1 Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Dacarbazine; Drug Therapy, Combination; Glioma; Humans; Lomustine; Medulloblastoma; Methotrexate; Nitrogen Mustard Compounds; Procarbazine; Semustine; Teniposide; Vincristine	1975

Trials

16 trial(s) available for arginine and Glioma

Article	Year
Predicting the probability of abnormal stimulated growth hormone response in children after radiotherapy for brain tumors. International journal of radiation oncology, biology, physics, 2012, Nov-15, Volume: 84, Issue:4 Topics: Adolescent; Arginine; Biomarkers; Brain Neoplasms; Child; Child, Preschool; Craniopharyngioma; Ependymoma; Feasibility Studies; Female; Glioma; Human Growth Hormone; Humans; Hypothalamus; Infant; Insulin-Like Growth Factor Binding Protein 3; Insulin-Like Growth Factor I; Levodopa; Logistic Models; Male; Models, Biological; Predictive Value of Tests; Probability; Prospective Studies; Radiotherapy Planning, Computer-Assisted; Radiotherapy, Conformal; ROC Curve; Sensitivity and Specificity	2012
[Comparison of two regimens of postoperative concurrent chemoradiotherapy in adult patients with grade III-IV cerebral gliomas]. Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2012, Volume: 32, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemoradiotherapy; Dacarbazine; Female; Glioma; Humans; Male; Middle Aged; Postoperative Period; Semustine; Temozolomide; Teniposide; Young Adult	2012
Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003, Sep-01, Volume: 21, Issue:17 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Disease Progression; Female; Glioblastoma; Glioma; Humans; Male; Middle Aged; Nimustine; Prognosis; Prospective Studies; Survival Analysis; Teniposide; Treatment Outcome	2003
Clinical trial of CPT-11 and VM-26/VP-16 for patients with recurrent malignant brain tumors. Journal of neuro-oncology, 2007, Volume: 82, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Camptothecin; Etoposide; Female; Glioma; Humans; Irinotecan; Magnetic Resonance Imaging; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Teniposide; Tomography, X-Ray Computed	2007
Intracarotid chemotherapy with a combination of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), cis-diaminedichloroplatinum (cisplatin), and 4'-O-demethyl-1-O-(4,6-O-2-thenylidene-beta-D-glucopyranosyl) epipodophyllotoxin (VM-26) in the treatment of primary Neurosurgery, 1984, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Carotid Arteries; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Ependymoma; Female; Glioma; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Oligodendroglioma; Teniposide; Tomography, X-Ray Computed	1984
Evaluation of CCNU, VM-26 plus CCNU, and procarbazine in supratentorial brain gliomas. Final evaluation of a randomized study. European Organization for Research on Treatment of Cancer (EORTC) Brain Tumor Group. Journal of neurosurgery, 1981, Volume: 55, Issue:1 Topics: Antineoplastic Agents; Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Procarbazine; Prospective Studies; Random Allocation; Teniposide	1981
Feasibility study of intraarterial vs intravenous cisplatin, BCNU, and teniposide combined with systemic cisplatin, teniposide, cytosine arabinoside, glycerol and mannitol in the treatment of primary and metastatic brain tumors. Journal of neuro-oncology, 1993, Volume: 17, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Cisplatin; Cytarabine; Female; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Male; Mannitol; Middle Aged; Survival Rate; Teniposide	1993
Treatment of malignant gliomas and brain metastases in adults using a combination of adriamycine, VM 26, and CCNU. Results of a type II trial. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1977, Issue:62 Topics: Adult; Aged; Brain Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Glioma; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1977
[A study of the use of sequential chemotherapy in 176 cases of glioblastoma (author's transl)]. Revue neurologique, 1978, Volume: 134, Issue:5 Topics: Adult; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Procarbazine; Random Allocation; Remission, Spontaneous; Teniposide; Time Factors	1978
[Surgically treated supratentorial gliomas in the adult. Favourable action of a podophyllin derivative (VM 26) administered alone (author's transl)]. La Nouvelle presse medicale, 1978, Dec-09, Volume: 7, Issue:44 Topics: Brain Neoplasms; Drug Tolerance; Glioma; Humans; Podophyllotoxin; Teniposide	1978
[Letter: Chemotherapy of operated malignant brain gliomas using a combination of VM 26 and CCNU]. La Nouvelle presse medicale, 1976, Feb-14, Volume: 5, Issue:7 Topics: Brain Neoplasms; Clinical Trials as Topic; Drug Therapy, Combination; Follow-Up Studies; Glioma; Humans; Lomustine; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1976
[Trial treatment of glioblastomas in adults and cerebral metastais by adriamycin, VM 26 and CCNU combination. Result of a type II trial]. La Nouvelle presse medicale, 1976, Jun-19, Volume: 5, Issue:25 Topics: Adult; Aged; Brain Neoplasms; Clinical Trials as Topic; Doxorubicin; Drug Evaluation; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Remission, Spontaneous; Teniposide	1976
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas. Journal of chemotherapy (Florence, Italy), 1992, Volume: 4, Issue:2 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Female; Glioblastoma; Glioma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Teniposide; Vincristine	1992
[Chemotherapy of malignant glioma. Results of studies of the EORTC group of brain tumors]. Revue neurologique, 1992, Volume: 148, Issue:6-7 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Glioma; Humans; Lomustine; Supratentorial Neoplasms; Survival Analysis; Teniposide	1992
Randomized trial of three chemotherapy regimens and two radiotherapy regimens and two radiotherapy regimens in postoperative treatment of malignant glioma. Brain Tumor Cooperative Group Trial 8001. Journal of neurosurgery, 1989, Volume: 71, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cerebellar Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Hydroxyurea; Postoperative Care; Procarbazine; Random Allocation; Teniposide	1989
Randomized phase III trial of single versus multiple chemotherapeutic treatment following surgery and during radiotherapy for patients with anaplastic gliomas. Surgical neurology, 1987, Volume: 27, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Clinical Trials as Topic; Combined Modality Therapy; Glioma; Humans; Hydroxyurea; Methylprednisolone; Middle Aged; Mitolactol; Procarbazine; Random Allocation; Teniposide; Tomography, X-Ray Computed	1987

Other Studies

79 other study(ies) available for arginine and Glioma

Article	Year
Characterisation of Expression the Arginine Pathway Enzymes in Childhood Brain Tumours to Determine Susceptibility to Therapeutic Arginine Depletion. BioMed research international, 2022, Volume: 2022 Topics: Adult; Arginase; Arginine; Argininosuccinate Lyase; Brain Neoplasms; Cerebellar Neoplasms; Child; Ependymoma; Glioma; Humans; Medulloblastoma; Ornithine Carbamoyltransferase	2022
GAS41 promotes H2A.Z deposition through recognition of the N terminus of histone H3 by the YEATS domain. Proceedings of the National Academy of Sciences of the United States of America, 2023, 10-24, Volume: 120, Issue:43 Topics: Arginine; Chromatin; Glioma; Histones; Humans; Protein Domains	2023
Sequence length dependence in arginine/phenylalanine oligopeptides: Implications for self-assembly and cytotoxicity. Biophysical chemistry, 2018, Volume: 233 Topics: Animals; Arginine; Cell Survival; Dose-Response Relationship, Drug; Glioma; Macrophages; Mice; Oligopeptides; Particle Size; Phenylalanine; Rats; RAW 264.7 Cells; Structure-Activity Relationship	2018
IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53. The Journal of biological chemistry, 2018, 06-22, Volume: 293, Issue:25 Topics: Animals; Arginine; Brain Neoplasms; Carcinogenesis; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glioma; Glutarates; Humans; Isocitrate Dehydrogenase; Mice; MicroRNAs; Mutation; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays	2018
Lack of B and T cell reactivity towards IDH1 Journal of neuro-oncology, 2019, Volume: 144, Issue:1 Topics: Arginine; B-Lymphocytes; Brain Neoplasms; Glioma; Humans; Isocitrate Dehydrogenase; Mutation; Prognosis; T-Lymphocytes	2019
A novel monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G mutation. Biochemical and biophysical research communications, 2013, Mar-22, Volume: 432, Issue:4 Topics: Amino Acid Substitution; Animals; Antibodies, Monoclonal; Arginine; Cell Line; Cricetinae; Glioma; Glycine; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Mice; Mutation; Rats; Staining and Labeling	2013
Establishment of a multi-specific monoclonal antibody MsMab-1 recognizing both IDH1 and IDH2 mutations. The Tohoku journal of experimental medicine, 2013, Volume: 230, Issue:2 Topics: Amino Acids; Animals; Antibodies, Monoclonal; Arginine; Brain Neoplasms; CHO Cells; Codon; Cricetulus; Enzyme-Linked Immunosorbent Assay; Glioma; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Mice; Mutation; Peptides; Recombinant Proteins	2013
Expression of PRMT5 correlates with malignant grade in gliomas and plays a pivotal role in tumor growth in vitro. Journal of neuro-oncology, 2014, Volume: 118, Issue:1 Topics: Adult; Aged; Arginine; Brain Neoplasms; Cell Differentiation; Cell Proliferation; Colonic Neoplasms; Colony-Forming Units Assay; Epithelium; Female; Glial Fibrillary Acidic Protein; Glioma; Humans; Male; MAP Kinase Signaling System; Middle Aged; Neurons; Phosphopyruvate Hydratase; Protein-Arginine N-Methyltransferases; RNA, Small Interfering	2014
Tumor-specific delivery of BSH-3R for boron neutron capture therapy and positron emission tomography imaging in a mouse brain tumor model. Biomaterials, 2015, Volume: 56 Topics: Animals; Arginine; Boron; Boron Neutron Capture Therapy; Boronic Acids; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Copper; Disease Models, Animal; Drug Delivery Systems; Female; Glioma; Heterocyclic Compounds, 1-Ring; Humans; Immunohistochemistry; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oligopeptides; Peptides; Positron-Emission Tomography; Tomography, X-Ray Computed	2015
In Silico prediction of the molecular basis of ClTx and AaCTx interaction with matrix metalloproteinase-2 (MMP-2) to inhibit glioma cell invasion. Journal of biomolecular structure & dynamics, 2017, Volume: 35, Issue:13 Topics: Arginine; Binding Sites; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Glioma; Humans; Matrix Metalloproteinase 2; Molecular Dynamics Simulation; Neoplasm Invasiveness; Peptides; Protein Binding; Scorpion Venoms	2017
Increase in brain tumor permeability in glioma-bearing rats with nitric oxide donors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Jun-15, Volume: 14, Issue:12 Topics: Administration, Oral; Animals; Arginine; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Citrulline; Cyclic GMP; Drug Delivery Systems; Drug Evaluation, Preclinical; Drug Synergism; Female; Glioma; Hydroxyurea; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Rats; Rats, Inbred F344; Tumor Cells, Cultured	2008
WRN Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil. Journal of neuro-oncology, 2008, Volume: 90, Issue:3 Topics: Adult; Arginine; Brazil; Case-Control Studies; Cysteine; Exodeoxyribonucleases; Female; Follow-Up Studies; Gene Frequency; Genotype; Glioma; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; RecQ Helicases; Risk; Survival Analysis; Werner Syndrome Helicase	2008
Thrombin enhances glioma growth. Acta neurochirurgica. Supplement, 2008, Volume: 102 Topics: Animals; Anticoagulants; Arginine; Behavior, Animal; Brain Neoplasms; Bromodeoxyuridine; Cell Line, Tumor; Cell Proliferation; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glioma; Hemostatics; Male; Neoplasm Transplantation; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Tetrazolium Salts; Thiazoles; Thrombin; Time Factors	2008
A monoclonal antibody IMab-1 specifically recognizes IDH1R132H, the most common glioma-derived mutation. Biochemical and biophysical research communications, 2009, Dec-18, Volume: 390, Issue:3 Topics: Animals; Antibodies, Monoclonal; Arginine; Cell Line, Tumor; Glioma; Histidine; Humans; Hybridomas; Immunohistochemistry; Isocitrate Dehydrogenase; Mice; Mice, Inbred BALB C; Mutant Proteins	2009
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature, 2009, Dec-10, Volume: 462, Issue:7274 Topics: Arginine; Brain Neoplasms; Catalytic Domain; Cell Line; Crystallography, X-Ray; Disease Progression; Enzyme Assays; Glioma; Glutarates; Histidine; Humans; Isocitrate Dehydrogenase; Ketoglutaric Acids; Models, Molecular; Mutant Proteins; Mutation; Protein Conformation	2009
Mutation-specific IDH1 antibody differentiates oligodendrogliomas and oligoastrocytomas from other brain tumors with oligodendroglioma-like morphology. Acta neuropathologica, 2011, Volume: 121, Issue:2 Topics: Adolescent; Adult; Aged; Antibodies; Arginine; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 19; Female; Glioma; Histidine; Humans; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Nerve Tissue Proteins; Oligodendroglioma; Young Adult	2011
R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult glioma. Acta neuropathologica, 2011, Volume: 121, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arginine; Child; Child, Preschool; Female; Glioma; Histidine; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Infant; Isocitrate Dehydrogenase; Male; Middle Aged; Mutation; Up-Regulation; Young Adult	2011
Active site mutant dimethylarginine dimethylaminohydrolase 1 expression confers an intermediate tumour phenotype in C6 gliomas. The Journal of pathology, 2011, Volume: 225, Issue:3 Topics: Amidohydrolases; Animals; Arginine; Catalytic Domain; Female; Glioma; Magnetic Resonance Imaging; Mice; Mice, Nude; Microscopy, Fluorescence; Mutation; Neoplasm Transplantation; Neovascularization, Pathologic; Phenotype; Rats; Transplantation, Heterologous; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A	2011
Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genetics and molecular research : GMR, 2011, Jun-14, Volume: 10, Issue:2 Topics: Arginine; Brain Neoplasms; DNA Primers; DNA-Binding Proteins; Glioma; Glycine; Humans; Polymerase Chain Reaction; Polymorphism, Single Nucleotide; Tryptophan; X-ray Repair Cross Complementing Protein 1	2011
Value and limitations of immunohistochemistry and gene sequencing for detection of the IDH1-R132H mutation in diffuse glioma biopsy specimens. Journal of neuropathology and experimental neurology, 2011, Volume: 70, Issue:8 Topics: Arginine; Biopsy; Brain Neoplasms; Genetic Testing; Glioma; Histidine; Humans; Immunohistochemistry; Isocitrate Dehydrogenase; Mutation; Reproducibility of Results; Sequence Analysis	2011
Glioma derived isocitrate dehydrogenase-2 mutations induced up-regulation of HIF-1α and β-catenin signaling: possible impact on glioma cell metastasis and chemo-resistance. The international journal of biochemistry & cell biology, 2012, Volume: 44, Issue:5 Topics: Animals; Arginine; beta Catenin; Brain Neoplasms; Cell Line, Tumor; Disease Progression; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Isocitrate Dehydrogenase; Isoenzymes; Mutation; Neoplasm Invasiveness; Rats; Signal Transduction; Transfection; Up-Regulation	2012
Screening of substrates of protein arginine methyltransferase 1 in glioma. Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih, 2012, Volume: 27, Issue:1 Topics: Arginine; Cell Line, Tumor; Chromatography, Liquid; Glioma; Humans; Immunoprecipitation; Protein-Arginine N-Methyltransferases; Repressor Proteins; Substrate Specificity; Tandem Mass Spectrometry	2012
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies. Current treatment options in oncology, 2012, Volume: 13, Issue:4 Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin	2012
Arginine modified PAMAM dendrimer for interferon beta gene delivery to malignant glioma. International journal of pharmaceutics, 2013, Mar-10, Volume: 445, Issue:1-2 Topics: Animals; Apoptosis; Arginine; Brain Neoplasms; Caspase 3; Cell Line; Cell Line, Tumor; Dendrimers; Gene Transfer Techniques; Genetic Therapy; Glioma; Humans; Interferon-beta; Mice; Mice, Nude; Tumor Burden; Xenograft Model Antitumor Assays	2013
Chitosan induces different L-arginine metabolic pathways in resting and inflammatory macrophages. Biochemical and biophysical research communications, 2003, May-02, Volume: 304, Issue:2 Topics: Animals; Arginase; Arginine; Cell Division; Cells, Cultured; Chitin; Chitosan; Female; Glioma; Inflammation; Macrophage Activation; Macrophages; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Wistar; Tumor Cells, Cultured	2003
A thrombin inhibitor reduces brain edema, glioma mass and neurological deficits in a rat glioma model. Acta neurochirurgica. Supplement, 2003, Volume: 86 Topics: Animals; Antithrombins; Arginine; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Glioma; Immunohistochemistry; Nervous System Diseases; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Thrombin	2003
The role of thrombin in gliomas. Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:9 Topics: Animals; Arginine; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Glioma; Humans; Male; Motor Activity; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Thrombin; Tumor Burden	2005
Systemic use of argatroban reduces tumor mass, attenuates neurological deficits and prolongs survival time in rat glioma models. Acta neurochirurgica. Supplement, 2005, Volume: 95 Topics: Animals; Anticoagulants; Antineoplastic Agents; Arginine; Brain; Brain Edema; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Glioma; Injections, Intraventricular; Male; Mental Disorders; Pipecolic Acids; Rats; Rats, Inbred F344; Sulfonamides; Survival Rate; Treatment Outcome	2005
PMS2 mutations in childhood cancer. Journal of the National Cancer Institute, 2006, Mar-01, Volume: 98, Issue:5 Topics: Adenosine Triphosphatases; Adolescent; Arginine; Astrocytoma; Cafe-au-Lait Spots; Child; Colonic Polyps; DNA Repair; DNA Repair Enzymes; DNA-Binding Proteins; Female; Founder Effect; Genetic Predisposition to Disease; Glioma; Humans; Leukemia, T-Cell; Lymphoma, B-Cell; Lymphoma, T-Cell; Male; Mismatch Repair Endonuclease PMS2; Mutation; Neoplasms; Neoplasms, Second Primary; Pakistan; Precursor Cell Lymphoblastic Leukemia-Lymphoma; United Kingdom	2006
Inhibition of glioma cell line A-172 MMP activity and cell invasion in vitro by a nutrient mixture. Medical oncology (Northwood, London, England), 2007, Volume: 24, Issue:2 Topics: Acetylcysteine; Amino Acids; Antineoplastic Agents; Arginine; Ascorbic Acid; Camellia sinensis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Collagen; Drug Combinations; Glioma; Humans; Laminin; Lysine; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Neoplasm Invasiveness; Plant Extracts; Proline; Proteoglycans	2007
TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer genetics and cytogenetics, 2008, Jan-01, Volume: 180, Issue:1 Topics: Adult; Arginine; Brain Neoplasms; Case-Control Studies; Codon; Combined Modality Therapy; Female; Gene Frequency; Genes, p53; Genetic Predisposition to Disease; Glioma; Humans; Male; Middle Aged; Polymorphism, Genetic; Proline; Retrospective Studies; Survival Rate; Treatment Outcome	2008
Interaction of feline sarcoma virus (FeSV) and mycoplasma. Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1981, Volume: 89, Issue:3 Topics: Animals; Arginine; Cats; Cell Division; Cell Line; Female; Fibroblasts; Glioma; Humans; Kanamycin; Mycoplasma; Pregnancy; Rabbits; Retroviridae; Sarcoma Viruses, Feline	1981
Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis. Blood, 1984, Volume: 64, Issue:1 Topics: Antibodies; Arginine; Blood Coagulation; Cell Line; Centrifugation, Density Gradient; Dansyl Compounds; Glioma; Humans; Neoplastic Stem Cells; Perfusion; Platelet Aggregation; Thromboplastin; Thrombosis	1984
Transport of L-arginine in cultured glial cells. Glia, 1994, Volume: 11, Issue:3 Topics: Amino Acids; Animals; Arginine; Astrocytes; Brain; Brain Neoplasms; Cells, Cultured; Glioma; Kinetics; Lipopolysaccharides; Mice; Neuroglia; Nitric Oxide; Potassium; Rats; Rats, Wistar; Tumor Cells, Cultured	1994
NG-methyl-L-arginine, an inhibitor of nitric oxide formation, reverses IL-2-mediated hypotension in dogs. Journal of applied physiology (Bethesda, Md. : 1985), 1994, Volume: 76, Issue:3 Topics: Animals; Antineoplastic Agents; Arginine; Blood Pressure; Blood Urea Nitrogen; Cell Division; Creatinine; Dogs; Enzymes; Glioma; Hypotension; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukocyte Count; Lymphocytes; Male; Monocytes; Nitric Oxide; omega-N-Methylarginine; Thrombocytopenia; Tumor Cells, Cultured	1994
Involvement of nitric oxide on the cytokine induced growth of glial cell. Biochemical and biophysical research communications, 1993, Jul-15, Volume: 194, Issue:1 Topics: Animals; Arginine; Cell Division; Cytokines; Glioma; Humans; Interferon-gamma; Interleukin-6; Isoquinolines; Kinetics; Lymphotoxin-alpha; Neuroglia; Nitric Oxide; omega-N-Methylarginine; Protein Kinase Inhibitors; Rats; Recombinant Proteins; Stereoisomerism; Sulfonamides; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha	1993
Differential regulation of intracellular signaling systems by sodium fluoride in rat glioma cells. Journal of neurochemistry, 1996, Volume: 66, Issue:4 Topics: Animals; Arginine; Calcium; Chelating Agents; Cyclic GMP; Egtazic Acid; Enzyme Inhibitors; Glioma; omega-N-Methylarginine; Rats; Serotonin; Signal Transduction; Sodium Fluoride; Sulfonamides; Time Factors; Tumor Cells, Cultured; Vasodilator Agents	1996
Cyclic GMP generation mediated by 5-HT-2 receptors via nitric oxide-dependent pathway and its effect on the desensitization of 5-HT-2 receptors in C6 glioma cells. Journal of neural transmission. General section, 1995, Volume: 100, Issue:1 Topics: Animals; Arginine; Calcium; Chelating Agents; Cyclic GMP; Dopamine Antagonists; Edetic Acid; Egtazic Acid; Glioma; Haloperidol; Ketanserin; Nitric Oxide; omega-N-Methylarginine; Rats; Receptors, Serotonin; Risperidone; Serotonin Antagonists; Tropanes; Tumor Cells, Cultured	1995
Increased brain tumor microvessel permeability after intracarotid bradykinin infusion is mediated by nitric oxide. Cancer research, 1996, Sep-01, Volume: 56, Issue:17 Topics: Aminoisobutyric Acids; Animals; Arginine; Blood-Brain Barrier; Blotting, Western; Bradykinin; Brain Neoplasms; Capillary Permeability; Carbon Radioisotopes; Dextrans; Enzyme Inhibitors; Female; Glioma; Immunohistochemistry; Infusions, Intra-Arterial; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Wistar; Tumor Cells, Cultured	1996
Expression of the surface antigen 4F2hc affects system-L-like neutral-amino-acid-transport activity in mammalian cells. The Biochemical journal, 1997, Jun-01, Volume: 324 ( Pt 2) Topics: Amino Acid Sequence; Amino Acids; Animals; Antigens, CD; Arginine; Astrocytes; Biological Transport; Brain; Carrier Proteins; Cells, Cultured; CHO Cells; COS Cells; Cricetinae; Cricetulus; DNA, Complementary; Fusion Regulatory Protein-1; Glioma; Isoleucine; Lymphocytes; Mammals; Mice; Molecular Sequence Data; Oligonucleotides, Antisense; Rats; Rats, Wistar; Recombinant Fusion Proteins; RNA, Messenger; Sequence Alignment; Sequence Homology; Transfection; Tumor Cells, Cultured	1997
Direct and continuous electrochemical measurement of noradrenaline-induced nitric oxide production in C6 glioma cells. Cellular and molecular neurobiology, 1998, Volume: 18, Issue:4 Topics: Animals; Arginine; Biosensing Techniques; Brain; Electrochemistry; Glioma; Interferon-gamma; Lipopolysaccharides; Neurons; Nitric Oxide; Norepinephrine; omega-N-Methylarginine; Signal Transduction; Tumor Cells, Cultured	1998
Effects of L-NMMA and L-NNA on the selective ATP-induced enhancement of intratumoral blood flow. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 1992, Volume: 12, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Animals; Arginine; Brain Neoplasms; Glioma; Male; Nitroarginine; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Regional Blood Flow; Tumor Cells, Cultured	1992
The hydrolytic activity in normal human and malignant tissue. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.), 1969, Volume: 131, Issue:3 Topics: Acid Phosphatase; Adenocarcinoma, Papillary; Alanine; Alkaline Phosphatase; Amides; Amidohydrolases; Arginine; Brain; Carcinoma, Intraductal, Noninfiltrating; Cecal Neoplasms; Cobalt; Dipeptidases; Female; Glioma; Humans; Leucine; Manganese; Naphthalenes; Ovarian Neoplasms; Peptide Hydrolases; Phenylalanine	1969
Paradoxical growth in a patient with the diencephalic syndrome. Pediatrics, 1970, Volume: 45, Issue:6 Topics: Arginine; Brain Neoplasms; Child; Child, Preschool; Diencephalon; Emaciation; Glioma; Glucose; Growth; Growth Disorders; Growth Hormone; Humans; Infant; Male; Metyrapone; Obesity; Optic Chiasm; Puberty, Precocious	1970
Prophylactic use of pegfilgrastim in patients treated with a nitrosourea and teniposide for recurrent glioma. Pharmacotherapy, 2014, Volume: 34, Issue:6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Communicable Diseases; Disease-Free Survival; Female; Filgrastim; Germany; Glioma; Granulocyte Colony-Stimulating Factor; Humans; Leukopenia; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Nimustine; Polyethylene Glycols; Recombinant Proteins; Retrospective Studies; Severity of Illness Index; Survival Rate; Teniposide	2014
Carmustine (BCNU) plus Teniposide (VM26) in recurrent malignant glioma. Oncology, 2014, Volume: 86, Issue:5-6 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carmustine; Disease-Free Survival; Female; Glioma; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Teniposide	2014
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC cancer, 2014, Aug-25, Volume: 14 Topics: Biomarkers, Tumor; Cell Line, Tumor; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Glioma; Humans; MicroRNAs; Prognosis; Proto-Oncogene Proteins c-mdm2; Teniposide; Tumor Cells, Cultured	2014
Study on the proliferation and drug-resistance of human brain tumor stem-like cells. Cellular and molecular neurobiology, 2010, Volume: 30, Issue:6 Topics: AC133 Antigen; Antigens, CD; Brain Neoplasms; Cell Death; Cell Differentiation; Cell Proliferation; Drug Resistance, Neoplasm; Flow Cytometry; Glioma; Glycoproteins; Humans; Neoplastic Stem Cells; Peptides; Spheroids, Cellular; Teniposide; Tumor Cells, Cultured	2010
[Nimotuzumab in combination with chemotherapy for patients with malignant gliomas]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:3 Topics: Adolescent; Adult; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Child; Cisplatin; Dacarbazine; Disease-Free Survival; Female; Glioblastoma; Glioma; Humans; Infusions, Intravenous; Male; Nausea; Neutropenia; Nimustine; Temozolomide; Teniposide; Thrombocytopenia; Young Adult	2011
Knockdown of AKT2 expression by RNA interference inhibits proliferation, enhances apoptosis, and increases chemosensitivity to the anticancer drug VM-26 in U87 glioma cells. Brain research, 2012, Aug-21, Volume: 1469 Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Glioma; HEK293 Cells; Humans; Proto-Oncogene Proteins c-akt; RNA Interference; Teniposide	2012
Hypofractionated stereotactic re-irradiation: treatment option in recurrent malignant glioma. BMC cancer, 2005, May-30, Volume: 5 Topics: Antineoplastic Agents; Brain Neoplasms; Disease Progression; Dose Fractionation, Radiation; Dose-Response Relationship, Radiation; Glioblastoma; Glioma; Humans; Neoplasm Recurrence, Local; Nimustine; Prognosis; Radiosurgery; Radiotherapy; Recurrence; Stereotaxic Techniques; Teniposide; Time Factors; Treatment Outcome	2005
VM-26 monochemotherapy trial in the treatment of recurrent supratentorial gliomas: preliminary report. Surgical neurology, 1981, Volume: 15, Issue:2 Topics: Anemia; Astrocytoma; Brain Neoplasms; Chemical and Drug Induced Liver Injury; Female; Glioblastoma; Glioma; Humans; Kidney Diseases; Male; Neoplasm Recurrence, Local; Oligodendroglioma; Podophyllotoxin; Teniposide	1981
[Antimitotic chemotherapy of supratentorial cerebral glioma in adults. Apropos of 56 cases]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Feb-17, Volume: 59, Issue:7 Topics: Adult; Aged; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1983
[Prognostic value of gliofibrillary protein assay in malignant gliomas treated with chemo- and radiotherapy]. La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1983, Feb-17, Volume: 59, Issue:7 Topics: Adolescent; Adult; Brain Neoplasms; Drug Therapy, Combination; Female; Follow-Up Studies; Glial Fibrillary Acidic Protein; Glioma; Humans; Intermediate Filament Proteins; Lomustine; Male; Middle Aged; Prognosis; Teniposide	1983
[Second-look operations and chemotherapy for malignant tumors of the brain]. Gan no rinsho. Japan journal of cancer clinics, 1983, Volume: 29, Issue:10 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Child; Female; Glioma; Humans; Male; Middle Aged; Nimustine; Nitrosourea Compounds; Reoperation; Teniposide	1983
[Synchronization chemoradiotherapy for malignant gliomas]. No shinkei geka. Neurological surgery, 1984, Volume: 12, Issue:7 Topics: Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Combined Modality Therapy; Glioma; Humans; Nimustine; Nitrosourea Compounds; Teniposide; Vincristine	1984
Etoposide (VP-16-213) in malignant brain tumors: a phase II study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1984, Volume: 2, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Drug Evaluation; Etoposide; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Podophyllotoxin; Teniposide; Time Factors; Tomography, X-Ray Computed	1984
Phase II study of VM-26 in adult malignancies. Cancer treatment reports, 1980, Volume: 64, Issue:1 Topics: Breast Neoplasms; Colonic Neoplasms; Drug Evaluation; Female; Glioma; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Podophyllotoxin; Teniposide; Thrombocytopenia	1980
Chemotherapy of human malignant glioma: prevention of efficacy by dexamethasone? Neurology, 1997, Volume: 48, Issue:6 Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; bcl-2-Associated X Protein; Cell Cycle; Cell Survival; Cytarabine; Dexamethasone; Doxorubicin; Drug Interactions; Glioma; Humans; Methotrexate; Nimustine; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Teniposide; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine	1997
Synergy of CD95 ligand and teniposide: no role of cleavable complex formation and enhanced CD95 expression. European journal of pharmacology, 1998, Jan-12, Volume: 341, Issue:2-3 Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Division; DNA Topoisomerases, Type II; Drug Synergism; Fas Ligand Protein; fas Receptor; Glioma; Humans; Membrane Glycoproteins; Teniposide; Tumor Cells, Cultured; Tumor Suppressor Protein p53	1998
Chemosensitivity of human malignant glioma: modulation by p53 gene transfer. Journal of neuro-oncology, 1998, Volume: 39, Issue:1 Topics: Amino Acid Substitution; Animals; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Brain Neoplasms; Carmustine; Cell Division; Cytarabine; Doxorubicin; Drug Resistance, Neoplasm; Gene Deletion; Gene Expression Regulation, Neoplastic; Genes, bcl-2; Genes, p53; Glioma; Humans; Mice; Point Mutation; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Recombinant Fusion Proteins; Temperature; Teniposide; Transfection; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine	1998
Accumulation of mutant p53(V143A) modulates the growth, clonogenicity, and radiochemosensitivity of malignant glioma cells independent of endogenous p53 status. Experimental cell research, 1999, Dec-15, Volume: 253, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Camptothecin; Carmustine; Cell Death; Cell Division; Cisplatin; Clone Cells; Combined Modality Therapy; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Gene Expression Regulation, Neoplastic; Genes, Dominant; Glioma; Humans; In Vitro Techniques; Paclitaxel; Point Mutation; Radiotherapy; Teniposide; Topotecan; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vincristine	1999
Caspase-dependent chemotherapy-induced death of glioma cells requires mitochondrial cytochrome c release. Biochemical and biophysical research communications, 2001, Feb-23, Volume: 281, Issue:2 Topics: Amino Acid Chloromethyl Ketones; Animals; Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspase 1; Caspase 2; Caspase 3; Caspase 7; Caspase 8; Caspase 9; Caspases; Cytochrome c Group; DNA, Recombinant; Glioma; Humans; Mitochondria; Proto-Oncogene Proteins c-bcl-2; Serpins; Teniposide; Transfection; Tumor Cells, Cultured; Vincristine; Viral Proteins	2001
Diva/Boo is a negative regulator of cell death in human glioma cells. FEBS letters, 2001, Sep-07, Volume: 505, Issue:1 Topics: Apoptotic Protease-Activating Factor 1; Caspase 3; Caspase 8; Caspase 9; Caspases; Cell Death; Central Nervous System Neoplasms; Coumarins; Culture Media, Serum-Free; Cytochrome c Group; Enzyme Inhibitors; Fas Ligand Protein; Genes, myc; Glioma; Humans; Membrane Glycoproteins; Nitrosourea Compounds; Oligopeptides; Proteins; Proto-Oncogene Proteins c-bcl-2; Teniposide; Transfection; Tumor Cells, Cultured	2001
[Enhanced cytotoxicity of VM-26 in human malignant glioma cells by calcium channel blocker nicardipine in vitro]. Hunan yi ke da xue xue bao = Hunan yike daxue xuebao = Bulletin of Hunan Medical University, 1999, Volume: 24, Issue:2 Topics: Antineoplastic Agents; Brain Neoplasms; Calcium Channel Blockers; Drug Synergism; Glioma; Humans; Nicardipine; Teniposide; Tumor Cells, Cultured	1999
[Role of VM26 on glioma cells in vitro--analysis of G0 cells and recruitment (author's transl)]. Neurologia medico-chirurgica, 1978, Volume: 18, Issue:6 Topics: Brain Neoplasms; Cells, Cultured; Glioma; Kinetics; Mitosis; Podophyllotoxin; Teniposide	1978
[Value of chemotherapy associated with conventional treatment of malignant gliomas of the brain. Study of 95 cases with histological verification and follow-up of 1 to 6 years 9 months]. Revue neurologique, 1979, Volume: 135, Issue:3 Topics: Administration, Oral; Adult; Brain Neoplasms; Carmustine; Drug Evaluation; Drug Therapy, Combination; Female; Follow-Up Studies; Glioblastoma; Glioma; Humans; Injections, Intravenous; Lomustine; Male; Middle Aged; Nitrosourea Compounds; Podophyllotoxin; Retrospective Studies; Teniposide	1979
Recruitment-chemoradiotherapy with VM 26 (epipodophyllotoxin) for induction treatment of malignant brain tumours. Acta neurochirurgica. Supplementum, 1979, Volume: 28, Issue:2 Topics: Adenocarcinoma; Animals; Brain Neoplasms; Cell Line; Fibrosarcoma; Glioma; Humans; Mitosis; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms, Experimental; Podophyllotoxin; Radiotherapy Dosage; Rats; Teniposide; Vincristine	1979
VM-26 as a second drug in the treatment of brain gliomas. Cancer treatment reports, 1979, Volume: 63, Issue:3 Topics: Antineoplastic Agents; Brain Neoplasms; Drug Therapy, Combination; Female; Glioma; Humans; Nitrosourea Compounds; Podophyllotoxin; Teniposide	1979
Malignant gliomas treated after surgery by combination chemotherapy and delayed radiation therapy. Part II. Tolerance to irradiation after chemotherapy. Acta neurochirurgica, 1979, Volume: 51, Issue:1-2 Topics: Brain; Brain Neoplasms; Drug Therapy, Combination; Glioma; Humans; Lomustine; Neoplasm Recurrence, Local; Nitrosourea Compounds; Podophyllotoxin; Radiation Tolerance; Radiotherapy; Radiotherapy Dosage; Teniposide	1979
Combined chemotherapy with VM 26 and BCNU for recurrent malignant gliomas after operation and irradiation. Acta neurochirurgica, 1978, Volume: 42, Issue:1-2 Topics: Adult; Aged; Brain Neoplasms; Carmustine; Drug Therapy, Combination; Female; Glioma; Humans; Male; Middle Aged; Podophyllotoxin; Postoperative Period; Teniposide	1978
[Neurogliale cerebral tumors: test of chemotherapy treatment. Forty five cases (author's transl)]. La Nouvelle presse medicale, 1978, Dec-02, Volume: 7, Issue:43 Topics: Adult; Aged; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Echoencephalography; Electroencephalography; Female; Follow-Up Studies; Glioma; Humans; Immunity, Cellular; Lomustine; Male; Middle Aged; Radionuclide Imaging; Teniposide	1978
Treatment of adult malignant gliomas. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1978, Volume: 68 Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Drug Therapy, Combination; Glioma; Humans; Lomustine; Middle Aged; Procarbazine; Teniposide	1978
[Comparative in vitro action of various antimitotic agents on cell lines established from human brain neoplasms]. Neuro-Chirurgie, 1976, Volume: 22, Issue:1 Topics: Antineoplastic Agents; Brain; Brain Neoplasms; Cell Division; Cell Line; Cells, Cultured; Embryo, Mammalian; Glioma; Humans; In Vitro Techniques; Meningioma; Teniposide	1976
Treatment of malignant gliomas and brain metastases in adults with a combination of adriamycin, VM 26, and CCNU. Results of a phase II trail. Cancer, 1976, Volume: 38, Issue:5 Topics: Adult; Aged; Brain Neoplasms; Doxorubicin; Drug Therapy, Combination; Drug Tolerance; Female; Glioma; Hematologic Diseases; Humans; Intracranial Pressure; Lomustine; Male; Middle Aged; Nausea; Neoplasm Metastasis; Nitrosourea Compounds; Podophyllotoxin; Teniposide; Vomiting	1976
[Chemotherapy in malignant gliomas]. Neurochirurgia, 1990, Volume: 33 Suppl 1 Topics: Antineoplastic Agents; Brain Neoplasms; Carmustine; Combined Modality Therapy; Cytarabine; Follow-Up Studies; Glioma; Humans; Nimustine; Survival Rate; Teniposide	1990
Combined intraarterial and systemic chemotherapy for intracerebral tumors. Neurosurgery, 1987, Volume: 21, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Carmustine; Cisplatin; Glioma; Glycerol; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Methotrexate; Middle Aged; Procarbazine; Teniposide; Vincristine	1987
Application of in vivo and in vitro pharmacokinetics for physiologically relevant drug exposure in a human tumor clonogenic cell assay. Cancer research, 1987, Jul-15, Volume: 47, Issue:14 Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Biological Assay; Brain Neoplasms; Carmustine; Cell Line; Cisplatin; Clone Cells; Dose-Response Relationship, Drug; Ellipticines; Glioma; Half-Life; Humans; Mathematics; Streptozocin; Teniposide	1987
Cytosine arabinoside plus cisplatin and other drugs as chemotherapy for gliomas. Seminars in oncology, 1987, Volume: 14, Issue:2 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Caffeine; Carmustine; Cisplatin; Cytarabine; Drug Synergism; Glioma; Humans; Teniposide	1987